Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Hepatitis B Virus Infection in Pregnant Women: Screening

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: July 2019

Workgroups: Immunization and Infectious Diseases Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends screening for hepatitis B virus (HBV) infection in pregnant people at their first prenatal visit. This usually involves a blood test to identify the HBsAg antigen. USPSTF notes that people need to get screened for HBV in each pregnancy even if they’ve been vaccinated against HBV or tested negative in the past.

Read more about this resource

Objectives related to this resource (1)

Reduce the rate of acute hepatitis B — IID‑11
Improving

Suggested Citation

1.

U.S. Preventive Services Task Force. (2019). Final Update Summary: Hepatitis B Virus Infection in Pregnant Women: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/hepatitis-b-virus-infection-in-pregnant-women-screening